Buy Tesamorelin 13mg/Ipamorelin 3mg Blend Research Peptide OnlineTesamorelin/ipamorelin formulation (13mg:3mg ratio, 16mg total) emphasizes GHRH-pathway dominance with minimal GHS-R contribution for comprehensive preclinical research into primary GHRH-receptor mechanisms. The 13:3 ratio enables detailed investigation of GHRH-primary somatotropic stimulation in controlled systems.Tesamorelin 13mg/Ipamorelin 3mg Blend Peptide Identification & CompositionTesamorelin (13mg): 44-amino acid synthetic GHRH agonist with enhanced proteolytic stability and receptor affinity. Ipamorelin (3mg): pentapeptide GHS-R1a agonist. The 13:3 ratio prioritizes GHRH signaling while providing supplementary ghrelin-receptor engagement for comparative investigation of pathway dominance effects in research models.Tesamorelin 13mg/Ipamorelin 3mg Blend Mechanism of Action in Preclinical SystemsTesamorelin predominantly engages GHRH receptors on pituitary somatotrophs. Ipamorelin contributes secondary GHS-R1a activation. Preclinical research demonstrates that this high GHRH:GHS-R ratio produces robust growth hormone secretion with GHRH-pathway dominance, enabling investigation of axis regulation when primary pathway stimulation is emphasized in controlled systems.Tesamorelin 13mg/Ipamorelin 3mg Blend Published Research SummaryLiterature in Neuroendocrinology and Endocrinology documents GHRH and GHS-R mechanisms extensively in preclinical research. Studies demonstrate that GHRH agonists alone produce significant growth hormone elevation. Preclinical research supports investigation of this peptide combination for understanding GHRH-dominant somatotropic regulation in controlled research environments.Tesamorelin 13mg/Ipamorelin 3mg Blend Product Specifications & Handling– Form: Lyophilized powder blend (acetate salts) – Quantity: 13mg tesamorelin 3mg ipamorelin (16mg total) – Molar Ratio: 13:3 (GHRH-dominant) – Purity: Research-grade (98% ) – Storage: -20°C freezer; protect from light and moisture – Reconstitution: Sterile saline or bacteriostatic water; room temperature equilibration – Stability: 2-3 weeks refrigerated post-reconstitutionTesamorelin 13mg/Ipamorelin 3mg Blend Research Use Only DisclaimerThis blend is intended exclusively for preclinical research and laboratory investigation. Not approved for human consumption, veterinary use, or clinical application. All use must comply with institutional research protocols.
